{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T03:31:23Z","timestamp":1767929483962,"version":"3.49.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R21\/R33AI079740"],"award-info":[{"award-number":["R21\/R33AI079740"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01DK107806"],"award-info":[{"award-number":["R01DK107806"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01CA161056"],"award-info":[{"award-number":["R01CA161056"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.jconrel.2017.01.036","type":"journal-article","created":{"date-parts":[[2017,1,31]],"date-time":"2017-01-31T09:15:55Z","timestamp":1485854155000},"page":"132-138","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Local enema treatment to inhibit FOLH1 \/GCPII as a novel therapy for inflammatory bowel disease"],"prefix":"10.1016","volume":"263","author":[{"given":"Abhijit A.","family":"Date","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rana","family":"Rais","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taarika","family":"Babu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jairo","family":"Ortiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pranjali","family":"Kanvinde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ajit G.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah C.","family":"Zimmermann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra J.","family":"Gadiano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gilad","family":"Halpert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara S.","family":"Slusher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura M.","family":"Ensign","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2017.01.036_bb0005","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/nature06005","article-title":"Unravelling the pathogenesis of inflammatory bowel disease","volume":"448","author":"Xavier","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2017.01.036_bb0010","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1172\/JCI30587","article-title":"The fundamental basis of inflammatory bowel disease","volume":"117","author":"Strober","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2017.01.036_bb0015","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/ncpgasthep0528","article-title":"Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis","volume":"3","author":"Sartor","year":"2006","journal-title":"Nat. Clin. Pract. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jconrel.2017.01.036_bb0020","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1146\/annurev-immunol-030409-101225","article-title":"Inflammatory bowel disease","volume":"28","author":"Kaser","year":"2010","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2017.01.036_bb0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00535-011-0521-8","article-title":"Update on biologic pathways in inflammatory bowel disease and their therapeutic relevance","volume":"47","author":"Hamilton","year":"2012","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.jconrel.2017.01.036_bb0030","article-title":"An ileal Crohn's disease gene signature based on whole human genome expression profiles of disease unaffected ileal mucosal biopsies","volume":"7","author":"Zhang","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2017.01.036_bb0035","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1097\/01.MIB.0000437045.26036.00","article-title":"Gene expression profiles of ileal inflammatory bowel disease correlate with disease phenotype and advance understanding of its immunopathogenesis","volume":"19","author":"Ben-Shachar","year":"2013","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.jconrel.2017.01.036_bb0040","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1002\/ibd.21263","article-title":"Characterization of intestinal gene expression profiles in Crohn's disease by genome-wide microarray analysis","volume":"16","author":"Noble","year":"2010","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.jconrel.2017.01.036_bb0045","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1021\/jm9905559","article-title":"Dual function glutamate-related ligands: discovery of a novel, potent inhibitor of glutamate carboxypeptidase II possessing mGluR3 agonist activity","volume":"43","author":"Nan","year":"2000","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jconrel.2017.01.036_bb0050","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1021\/jm000406m","article-title":"Design of remarkably simple, yet potent urea-based inhibitors of glutamate carboxypeptidase II (NAALADase)","volume":"44","author":"Kozikowski","year":"2001","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jconrel.2017.01.036_bb0055","doi-asserted-by":"crossref","first-page":"4140","DOI":"10.1021\/jm010561g","article-title":"Molecular modeling of the interactions of glutamate carboxypeptidase II with its potent NAAG-based inhibitors","volume":"45","author":"Rong","year":"2002","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jconrel.2017.01.036_bb0060","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1021\/jm0306226","article-title":"Synthesis of urea-based inhibitors as active site probes of glutamate carboxypeptidase II: efficacy as analgesic agents","volume":"47","author":"Kozikowski","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jconrel.2017.01.036_bb0065","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.2174\/092986712799462658","article-title":"Structure-activity relationships of glutamate carboxypeptidase II (GCPII) inhibitors","volume":"19","author":"Ferraris","year":"2012","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.jconrel.2017.01.036_bb0070","doi-asserted-by":"crossref","first-page":"5922","DOI":"10.1021\/jm300488m","article-title":"Design, synthesis, and pharmacological evaluation of glutamate carboxypeptidase II (GCPII) inhibitors based on thioalkylbenzoic acid scaffolds","volume":"55","author":"Stoermer","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jconrel.2017.01.036_bb0075","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1021\/acs.jmedchem.6b00062","article-title":"Discovery of orally available prodrugs of the glutamate carboxypeptidase II (GCPII) inhibitor 2-phosphonomethylpentanedioic acid (2-pmpa)","volume":"59","author":"Majer","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jconrel.2017.01.036_bb0080","doi-asserted-by":"crossref","first-page":"4539","DOI":"10.1021\/acs.jmedchem.5b01806","article-title":"Unprecedented binding mode of hydroxamate-based inhibitors of glutamate carboxypeptidase II: structural characterization and biological activity","volume":"59","author":"Novakova","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jconrel.2017.01.036_bb0085","series-title":"JCI Insight","article-title":"FOLH1\/GCPII is elevated in IBD patients, and its inhibition ameliorates murine IBD abnormalities","volume":"1","author":"Rais","year":"2016"},{"key":"10.1016\/j.jconrel.2017.01.036_bb0090","first-page":"309","article-title":"Advantages in IBD: current developments in the treatment of inflammatory bowel diseases","volume":"6","author":"Cohen","year":"2010","journal-title":"Gastroenterol. Hepatol."},{"key":"10.1016\/j.jconrel.2017.01.036_bb0095","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1586\/ecp.12.2","article-title":"Mesalamine in the treatment and maintenance of remission of ulcerative colitis","volume":"5","author":"Ham","year":"2012","journal-title":"Expert. Rev.Clin. Pharmacol."},{"key":"10.1016\/j.jconrel.2017.01.036_bb0100","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.3109\/03639045.2011.560156","article-title":"Multiparticulate systems containing 5-aminosalicylic acid for the treatment of inflammatory bowel disease","volume":"37","author":"Bautzova","year":"2011","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.jconrel.2017.01.036_bb0105","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD007698.pub2","article-title":"Oral budesonide for induction of remission in ulcerative colitis","author":"Sherlock","year":"2010","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.jconrel.2017.01.036_bb0110","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.crohns.2013.08.007","article-title":"Combined oral and rectal mesalazine for the treatment of mild-to-moderately active ulcerative colitis: rapid symptom resolution and improvements in quality of life","volume":"8","author":"Probert","year":"2014","journal-title":"J. Crohns Colitis"},{"key":"10.1016\/j.jconrel.2017.01.036_bb0115","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jconrel.2015.04.040","article-title":"Enema ion compositions for enhancing colorectal drug delivery","volume":"209","author":"Maisel","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.01.036_bb0120","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1021\/jm950801q","article-title":"Design, synthesis, and biological activity of a potent inhibitor of the neuropeptidase N-acetylated alpha-linked acidic dipeptidase","volume":"39","author":"Jackson","year":"1996","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jconrel.2017.01.036_bb0125","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1172\/JCI106100","article-title":"Effects of sodium concentration and osmolality on water and electrolyte absorption from the intact human colon","volume":"48","author":"Billich","year":"1969","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2017.01.036_bb0130","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S0003-2697(02)00286-5","article-title":"Kinetics and inhibition of glutamate carboxypeptidase II using a microplate assay","volume":"310","author":"Rojas","year":"2002","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.jconrel.2017.01.036_bb0135","doi-asserted-by":"crossref","first-page":"14498","DOI":"10.1016\/S0021-9258(18)47823-4","article-title":"Hydrolysis of the brain dipeptide N-acetyl-l-aspartyl-l-glutamate. Identification and characterization of a novel N-acetylated alpha-linked acidic dipeptidase activity from rat brain","volume":"262","author":"Robinson","year":"1987","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2017.01.036_bb0140","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jpba.2013.08.028","article-title":"Bioanalytical method for evaluating the pharmacokinetics of the GCP-II inhibitor 2-phosphonomethyl pentanedioic acid (2-PMPA)","volume":"88","author":"Rais","year":"2013","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jconrel.2017.01.036_bb0145","series-title":"Current Protocols in Immunology","article-title":"Induction of TNBS colitis in mice","author":"Scheiffele","year":"2002"},{"key":"10.1016\/j.jconrel.2017.01.036_bb0150","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jconrel.2014.10.026","article-title":"Effect of surface chemistry on nanoparticle interaction with gastrointestinal mucus and distribution in the gastrointestinal tract following oral and rectal administration in the mouse","volume":"197","author":"Maisel","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.01.036_bb0155","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nprot.2007.41","article-title":"Chemically induced mouse models of intestinal inflammation","volume":"2","author":"Wirtz","year":"2007","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.jconrel.2017.01.036_bb0160","doi-asserted-by":"crossref","first-page":"125","DOI":"10.2147\/CEG.S80237","article-title":"Rectal budesonide and mesalamine formulations in active ulcerative proctosigmoiditis: efficacy, tolerance, and treatment approach","volume":"9","author":"Christophi","year":"2016","journal-title":"Clin. Exp. Gastroenterol."},{"key":"10.1016\/j.jconrel.2017.01.036_bb0165","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1136\/gut.43.2.294","article-title":"Salt and water absorption in the human colon: a modern appraisal","volume":"43","author":"Sandle","year":"1998","journal-title":"Gut"},{"key":"10.1016\/j.jconrel.2017.01.036_bb0170","doi-asserted-by":"crossref","first-page":"6922","DOI":"10.1016\/j.biomaterials.2013.05.039","article-title":"Enhanced vaginal drug delivery through the use of hypotonic formulations that induce fluid uptake","volume":"34","author":"Ensign","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2017.01.036_bb0175","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.nbd.2016.06.010","article-title":"Maternal inflammation leads to impaired glutamate homeostasis and up-regulation of glutamate carboxypeptidase II in activated microglia in the fetal\/newborn rabbit brain","volume":"94","author":"Zhang","year":"2016","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jconrel.2017.01.036_bb0180","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1136\/gut.52.1.65","article-title":"Increased expression of interleukin 17 in inflammatory bowel disease","volume":"52","author":"Fujino","year":"2003","journal-title":"Gut"},{"key":"10.1016\/j.jconrel.2017.01.036_bb0185","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1038\/70971","article-title":"Selective inhibition of NAALADase, which converts NAAG to glutamate, reduces ischemic brain injury","volume":"5","author":"Slusher","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2017.01.036_bb0190","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.nbd.2015.08.017","article-title":"Differential effects of N-acetyl-aspartyl-glutamate on synaptic and extrasynaptic NMDA receptors are subunit- and pH-dependent in the CA1 region of the mouse hippocampus","volume":"82","author":"Khacho","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jconrel.2017.01.036_bb0195","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1038\/nrd1903","article-title":"NAAG peptidase inhibitors and their potential for diagnosis and therapy","volume":"4","author":"Zhou","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2017.01.036_bb0200","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/j.1471-4159.2011.07338.x","article-title":"Advances in understanding the peptide neurotransmitter NAAG and appearance of a new member of the NAAG neuropeptide family","volume":"118","author":"Neale","year":"2011","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jconrel.2017.01.036_bb0205","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1007\/s00702-014-1167-5","article-title":"The neurotransmitter glutamate and human T cells: glutamate receptors and glutamate-induced direct and potent effects on normal human T cells, cancerous human leukemia and lymphoma T cells, and autoimmune human T cells","volume":"121","author":"Ganor","year":"2014","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.jconrel.2017.01.036_bb0210","doi-asserted-by":"crossref","first-page":"3438","DOI":"10.1111\/febs.13816","article-title":"Blocking glutamate carboxypeptidase II inhibits glutamate excitotoxicity and regulates immune responses in experimental autoimmune encephalomyelitis","volume":"283","author":"Ha","year":"2016","journal-title":"FEBS J."},{"key":"10.1016\/j.jconrel.2017.01.036_bb0215","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1124\/pr.110.004036","article-title":"Exciting times beyond the brain: metabotropic glutamate receptors in peripheral and non-neural tissues","volume":"63","author":"Julio-Pieper","year":"2011","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.jconrel.2017.01.036_bb0220","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJMra020831","article-title":"Inflammatory bowel disease","volume":"347","author":"Podolsky","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2017.01.036_bb0225","doi-asserted-by":"crossref","first-page":"3228","DOI":"10.1111\/febs.12857","article-title":"Structural and biochemical characterization of the folyl-poly-gamma-l-glutamate hydrolyzing activity of human glutamate carboxypeptidase II","volume":"281","author":"Navr\u00e1til","year":"2014","journal-title":"FEBS J."},{"key":"10.1016\/j.jconrel.2017.01.036_bb0230","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1517\/14728214.2012.744820","article-title":"Immunosuppressive and biologic therapy for ulcerative colitis","volume":"17","author":"Ardizzone","year":"2012","journal-title":"Expert Opin. Emerg. Drugs"},{"key":"10.1016\/j.jconrel.2017.01.036_bb0235","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s10456-016-9521-x","article-title":"Prostate-specific membrane antigen (PSMA)-mediated laminin proteolysis generates a pro-angiogenic peptide","volume":"19","author":"Conway","year":"2016","journal-title":"Angiogenesis"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365917300378?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365917300378?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,23]],"date-time":"2022-07-23T02:22:40Z","timestamp":1658542960000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365917300378"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":47,"alternative-id":["S0168365917300378"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2017.01.036","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Local enema treatment to inhibit FOLH1\/GCPII as a novel therapy for inflammatory bowel disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2017.01.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}